MiNK

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

MiNK

Oct 4, 2024, 16:04 | Insight

Thiago Favano: Our study on Palliative Care for Patients with Hematologic Malignancies in Brazil

Thiago Favano shared a post on LinkedIn about a recent paper by Alini Maria Orathes…

Mar 30, 2024, 14:12 | Blog

Jennifer Buell: I ride in the Pan Mass Challenge to eliminate the premature loss of so many important lives, to stand with our fighters, to illuminate hope

Jennifer Buell, the President and Chief Executive Officer of MiNK Therapeutics, shared on LinkedIn: "I…

Feb 8, 2024, 21:20 | Blog

Justin Stebbing: The first time invariant natural killer cells has ever been used as a cell therapy

Justin Stebbing shared a post on LinkedIn: “Super-thrilled to see our paper finally out in Nature…

Jun 2, 2023, 21:28 | Drugs

Spotlight on MiNK: Advancing Allogeneic iNKT Cell Therapies for Solid Tumor Cancers

Tune in to WBZ | CBS Boston for an insightful look into how MiNK is…

All: 4 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023